Nuzenio

Leerink Partners Adjusts

Leerink Partners Adjusts news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Leerink Partners Adjusts Price Target on Cencora to $380 From $368 - MoomooMoomoo · Fri, 07 Aug 2026 13:00:35 GMTLeerink Partners Adjusts Price Target on Zimmer Biomet to $106 From $90 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 16:05:19 GMTDA Davidson Adjusts Price Target on IDEX to $240 From $230 - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 15:59:38 GMTLeerink Partners Downgrades Insulet to Market Perform From Outperform, Adjusts PT to $145 From $247 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 13:30:23 GMTLeerink Partners Adjusts PT on Eli Lilly and Co. to $1,309 From $1,232, Maintains Outperform Rating - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 09:37:41 GMTLeerink Partners Adjusts Price Target on AbbVie to $279 From $245 - MoomooMoomoo · Wed, 05 Aug 2026 15:30:35 GMTLeerink Partners Adjusts Price Target on Gilead Sciences to $130 From $126 - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 14:11:19 GMTLeerink Partners Adjusts PT on Henry Schein to $96 From $88, Maintains Market Perform Rating - MoomooMoomoo · Wed, 05 Aug 2026 12:24:44 GMT

Timeline

Fri, 07 Aug 2026 13:00:35 GMTLeerink Partners Adjusts Price Target on Cencora to $380 From $368 - Moomoo
Thu, 06 Aug 2026 16:05:19 GMTLeerink Partners Adjusts Price Target on Zimmer Biomet to $106 From $90 - marketscreener.com
Thu, 06 Aug 2026 15:59:38 GMTDA Davidson Adjusts Price Target on IDEX to $240 From $230 - Yahoo Finance
Thu, 06 Aug 2026 13:30:23 GMTLeerink Partners Downgrades Insulet to Market Perform From Outperform, Adjusts PT to $145 From $247 - marketscreener.com
Thu, 06 Aug 2026 09:37:41 GMTLeerink Partners Adjusts PT on Eli Lilly and Co. to $1,309 From $1,232, Maintains Outperform Rating - marketscreener.com
Wed, 05 Aug 2026 15:30:35 GMTLeerink Partners Adjusts Price Target on AbbVie to $279 From $245 - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Leerink Partners Adjusts.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.